Effector Therapeutics Inc. logo

Effector Therapeutics Inc. (EFTR)

Market Open
12 Jun, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
941 Market Cap
- P/E Ratio
- Div Yield
331 Volume
0 Eps
$ 0
Previous Close
Analysts:
Add Transaction
Day Range
0 0
Year Range
0 0.01
Want to track EFTR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Effector Therapeutics Inc. (EFTR) Statistics

Valuation metrics

Market Cap 941
Enterprise value 5.67M
Trailing P/E (ttm) -0
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) -0
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.17

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 551
Average volume (90 days) 1.54K

Price summary

52-Week low 0
52-Week high 0.01
Beta -
50-Day moving average 0
200-Day moving average 0

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 12 Jan 2024

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -
Operating margin -

Operational effectiveness

Return on assets -1.74%
Return on equity 37.72%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -16.37
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 8.4
Total debt (mrq) -
Total Debt/Equity (mrq) -3.55
Current ratio (mrq) 0.77%
Book value per share (mrq) -2.65

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -